In recent years, anti-VEGF agents have been introduced and rapidly become an important therapy in the treatment of ocular vascular diseases, including age-related macular degeneration, diabetic macular edema, retinal vein occlusion and mCNV [22-24,66-70]. The gene discussed is VEGFA; the disease is age-related macular degeneration.